Intelligent Investor

MGC Pharmaceuticals Ltd (ASX: MXC) - Share Price and Research

Current share price for MXC : $0.420 0.01 (2.44%)

MXC General Information +

ASX Code MXC
Website N/A
Industry/Sector n/a
Market Cap ($M) 18
MXC Share Price $0.420
Day High $0.420
Day Low $0.395
Last Close $0.410
MXC Share Price Movement $0.01 ( 2.44% )
Prices as at 16:35, 2 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
Upsell Banner

MXC Related Research

MGC Pharmaceuticals Ltd (MXC) Upcoming Dividends & Yields

There are no dividends for MGC Pharmaceuticals Ltd (MXC). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

MGC Pharmaceuticals Ltd (MXC) Recent ASX Announcements

Headline Annoucement date/time+ Price at announcement+ Current price+ Price 7D Avg Gain/Loss
Change of Company Name 2 Apr 2024 9:48AM $0.410 $0.420 $0.395 risen by 2.44%
s708A Cleansing Notice 28 Mar 2024 5:37PM $0.410 $0.420 $0.395 risen by 2.44%
Application for quotation of securities - MXC 28 Mar 2024 5:34PM $0.410 $0.420 $0.395 risen by 2.44%
  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

See all ASX announcements from MGC Pharmaceuticals Ltd (MXC) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

MGC Pharmaceuticals Ltd (MXC) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
6 May 2022 ZOMER, Roby Buy Indirect Shares 819,672 $0.023 $19,192.000
6 May 2022 PARKER, Stephen Buy Indirect Shares 1,111,111 $0.014 $15,011.950
30 Sep 2021 HAYES, Evan Buy Direct Shares 295,000 $0.060 $17,655.750

See all changes in directors' interest & trades for MGC Pharmaceuticals Ltd (MXC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

FAQs about MGC Pharmaceuticals Ltd (MXC)

MGC Pharmaceuticals Ltd's (MXC) current share price is $0.42. This constitutes a price movement of 6.33% when compared to the share price 7 days ago and is -63.79% below MXC's 12-month high of $1.16 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $0.41, MGC Pharmaceuticals Ltd's (MXC) current share price of $0.42 constitutes a movement of $0.01 or 2.44%. MGC Pharmaceuticals Ltd's (MXC) share price movement is 6.33% when compared to 7 days ago and is -63.79% below MXC's 52-week high of $1.16.

MGC Pharmaceuticals Ltd's (MXC) 52-week high is $1.16 which was reached on 16 Nov 2023. Relative to this, MXC's current share price of $0.42 constitutes a -$0.74 or -63.79% drop since that high of $1.16 per MXC share.

MGC Pharmaceuticals Ltd's (MXC) 52-week low is $0.00 which was reached on 27 Sep 2023. Relative to this, MXC's current share price of $0.42 constitutes a $0.42 or 41,900% gain since that low of $0.00 per MXC share.

Over the last 12 months, MGC Pharmaceuticals Ltd (MXC) has a daily average trading volume of 2,558,134 MXC shares per day.

MGC Pharmaceuticals Ltd (MXC) has a current dividend yield of n/a this year. Last year's dividend yield was n/a. The dividend yield for MXC is a ratio that tells you the percentage of MGC Pharmaceuticals Ltd's (MXC) share price that it pays out in dividends each year.

MGC Pharmaceuticals Ltd (MXC) will release its next Annual Report on n/a. MGC Pharmaceuticals Ltd's (MXC) last annual report was released on 29 Sep 2023. Click here to view MGC Pharmaceuticals Ltd's (MXC) last annual report.

MGC Pharmaceuticals Ltd (MXC) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.